Arch Biopartners Inc
XTSX:ARCH
Balance Sheet
Balance Sheet Decomposition
Arch Biopartners Inc
Arch Biopartners Inc
Balance Sheet
Arch Biopartners Inc
| Sep-2010 | Sep-2011 | Sep-2012 | Sep-2013 | Sep-2014 | Sep-2015 | Sep-2016 | Sep-2017 | Sep-2018 | Sep-2019 | Sep-2020 | Sep-2021 | Sep-2022 | Sep-2023 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||
| Cash & Cash Equivalents |
1
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
1
|
0
|
1
|
0
|
0
|
|
| Cash |
1
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
1
|
0
|
1
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
1
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
1
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
1
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
1
|
1
|
3
|
1
|
1
|
1
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
1
N/A
|
0
-59%
|
0
-59%
|
0
-56%
|
0
+925%
|
1
+58%
|
0
-65%
|
0
-70%
|
1
+1 159%
|
1
-3%
|
1
-11%
|
3
+260%
|
1
-77%
|
1
+88%
|
1
-20%
|
|
| Liabilities | ||||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
2
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
4
|
1
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
3
|
3
|
6
|
5
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
3
|
3
|
3
|
2
|
1
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
+8%
|
0
+13%
|
0
+2%
|
0
-11%
|
1
+24%
|
1
0%
|
1
+25%
|
2
+172%
|
3
+102%
|
5
+33%
|
7
+42%
|
5
-22%
|
7
+31%
|
5
-21%
|
|
| Equity | ||||||||||||||||
| Common Stock |
7
|
7
|
8
|
8
|
9
|
9
|
10
|
10
|
12
|
12
|
14
|
15
|
16
|
16
|
17
|
|
| Retained Earnings |
7
|
8
|
8
|
8
|
9
|
9
|
11
|
12
|
15
|
18
|
22
|
23
|
25
|
28
|
29
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
3
|
3
|
5
|
5
|
5
|
7
|
8
|
|
| Total Equity |
0
N/A
|
0
N/A
|
0
-112%
|
0
-19%
|
0
+98%
|
0
N/A
|
0
N/A
|
1
-102%
|
1
-53%
|
3
-205%
|
4
-47%
|
4
0%
|
4
-15%
|
6
-23%
|
4
+21%
|
|
| Total Liabilities & Equity |
1
N/A
|
0
-59%
|
0
-59%
|
0
-56%
|
0
+925%
|
1
+58%
|
0
-65%
|
0
-70%
|
1
+1 159%
|
1
-3%
|
1
-11%
|
3
+260%
|
1
-77%
|
1
+88%
|
1
-20%
|
|
| Shares Outstanding | ||||||||||||||||
| Common Shares Outstanding |
47
|
47
|
48
|
48
|
51
|
53
|
54
|
55
|
58
|
59
|
61
|
62
|
62
|
63
|
65
|
|